Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mélanie Claps
Observed names:
M Claps,
M L Claps,
M. Claps,
Melanie CLAPS,
Melanie Claps
Institution:
Fondazione IRCCS Istituto Nazionale dei Tumori
Observed institutions:
Memorial Sloan Kettering Cancer Center,
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia,
Fondazione IRCCS Istituto Nazionale dei Tumori,
University of Brescia
ORCID:
0000-0001-7932-7898
Observed ORCID:
0000-0001-7932-7898
OpenAlex ID:
A5042759320
Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical Carcinoma
2017
·
Alfredo Berruti
, Salvatore Grisanti
, et al.
·
The Journal of Clinical Endocrinology & Metabolism
·
146
PDF
Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer
2020
·
Alessandra Raimondi
, Pierangela Sepe
, et al.
·
Frontiers in Oncology
·
78
PDF
Cabozantinib as First-line Treatment in Patients With Metastatic Collecting Duct Renal Cell Carcinoma: Results of the BONSAI Trial for the Italian Network for Research in Urologic-Oncology (Meet-URO 2 Study)
2022
·
Giuseppe Procopio
, Pierangela Sepe
, et al.
·
JAMA Oncology
·
70
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
2024
·
Brigida Anna Maiorano
, Massimo Di Maio
, et al.
·
JAMA Network Open
·
67
Testosterone Levels and Prostate Cancer Prognosis: Systematic Review and Meta-analysis
2018
·
Mélanie Claps
, Fausto Petrelli
, et al.
·
Clinical Genitourinary Cancer
·
62
A multicenter phase 2 single arm study of cabozantinib in patients with advanced or unresectable renal cell carcinoma pre-treated with one immune-checkpoint inhibitor: The BREAKPOINT trial (Meet-Uro trial 03)
2022
·
Giuseppe Procopio
, Mélanie Claps
, et al.
·
Tumori Journal
·
58
Sorafenib Versus Observation Following Radical Metastasectomy for Clear-cell Renal Cell Carcinoma: Results from the Phase 2 Randomized Open-label RESORT Study
2019
·
Giuseppe Procopio
, Giulia Apollonio
, et al.
·
European Urology Oncology
·
57
Immune-checkpoint inhibitors and metastatic prostate cancer therapy: Learning by making mistakes
2020
·
Mélanie Claps
, Alessia Mennitto
, et al.
·
Cancer Treatment Reviews
·
54
Analysis of Single Circulating Tumor Cells in Renal Cell Carcinoma Reveals Phenotypic Heterogeneity and Genomic Alterations Related to Progression
2020
·
Vera Cappelletti
, Elena Verzoni
, et al.
·
International Journal of Molecular Sciences
·
48
PDF
Current Understanding of Urachal Adenocarcinoma and Management Strategy
2020
·
Mélanie Claps
, Marco Stellato
, et al.
·
Current Oncology Reports
·
48
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study
2016
·
Chiara Fiorentini
, Martina Fragni
, et al.
·
The Journal of Clinical Endocrinology & Metabolism
·
42
PDF
Characteristics and Treatment Challenges of Non-Clear Cell Renal Cell Carcinoma
2021
·
Pierangela Sepe
, Arianna Ottini
, et al.
·
Cancers
·
38
PDF
Angiogenesis and Immunity in Renal Carcinoma: Can We Turn an Unhappy Relationship into a Happy Marriage?
2020
·
Alessia Mennitto
, Veronica Huber
, et al.
·
Journal of Clinical Medicine
·
37
PDF
In vitro antitumor activity of progesterone in human adrenocortical carcinoma
2018
·
Martina Fragni
, Chiara Fiorentini
, et al.
·
Endocrine
·
32
PDF
Adding metyrapone to chemotherapy plus mitotane for Cushing’s syndrome due to advanced adrenocortical carcinoma
2017
·
Mélanie Claps
, Sara Cerri
, et al.
·
Endocrine
·
32
PDF
Collecting ducts carcinoma: An orphan disease. Literature overview and future perspectives
2019
·
Filippo Pagani
, Maurizio Colecchia
, et al.
·
Cancer Treatment Reviews
·
30
Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study
2018
·
Rebecca Pedersini
, Lucia Vassalli
, et al.
·
Oncology
·
28
The Evaluation of Response to Immunotherapy in Metastatic Renal Cell Carcinoma: Open Challenges in the Clinical Practice
2019
·
Alessandra Raimondi
, Giovanni Randon
, et al.
·
International Journal of Molecular Sciences
·
25
PDF
Could Circulating Tumor Cells and ARV7 Detection Improve Clinical Decisions in Metastatic Castration-Resistant Prostate Cancer? The Istituto Nazionale dei Tumori (INT) Experience
2019
·
Pierangela Sepe
, Elena Verzoni
, et al.
·
Cancers
·
23
PDF
Current Status of Predictive Biomarker Development in Metastatic Renal Cell Carcinoma
2023
·
Giuseppe Fotia
, Marco Stellato
, et al.
·
Current Oncology Reports
·
18
Characterization of complete responders to nivolumab + gemcitabine-cisplatin vs gemcitabine-cisplatin alone and patients with lymph node–only metastatic urothelial carcinoma from the CheckMate 901 trial.
2024
·
Matt D. Galsky
, Guru P. Sonpavde
, et al.
·
Journal of Clinical Oncology
·
17
Characterization of Patients with Lymph Node Only Metastatic Urothelial Carcinoma Treated with Nivolumab Plus Gemcitabine-Cisplatin Versus Gemcitabine-Cisplatin Alone from the CheckMate 901 Trial
2025
·
Matthew D. Galsky
, Michiel S. van der Heijden
, et al.
·
European Urology
·
16
Prediction of Grade Reclassification of Prostate Cancer Patients on Active Surveillance through the Combination of a Three-miRNA Signature and Selected Clinical Variables
2021
·
Paolo Gandellini
, Chiara Maura Ciniselli
, et al.
·
Cancers
·
15
PDF
The emerging role of PARP inhibitors in prostate cancer
2020
·
Marco Stellato
, Valentina Guadalupi
, et al.
·
Expert Review of Anticancer Therapy
·
15
Cell-cycle distribution of urothelial tumour cells as measured by flow cytometry
1979
·
L G Collste
, Z Darzynkiewicz
, et al.
·
British Journal of Cancer
·
15
PDF
Show more works
View as search
Works count:
122
Citation count:
1,306
H-index:
19
I10-index:
33
Year
Topic
Type